Your browser doesn't support javascript.
loading
Resolution of Cryptosporidiosis in Transplant Recipients: Review of the Literature and Presentation of a Renal Transplant Patient Treated With Nitazoxanide, Azithromycin, and Rifaximin.
Tomczak, Ewa; McDougal, April N; White, A Clinton.
Afiliación
  • Tomczak E; Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • McDougal AN; Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • White AC; Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
Open Forum Infect Dis ; 9(1): ofab610, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34993260
ABSTRACT

BACKGROUND:

Cryptosporidium is a major cause of diarrheal disease worldwide, including chronic disease in malnourished children and patients with acquired immune deficiency syndrome. There are increasing reports of cryptosporidiosis in transplant patients, especially from middle-income countries.

METHODS:

The literature on treatment of cryptosporidiosis in transplant patients was reviewed and included no controlled trials but only small case series. Nitazoxanide, azithromycin, spiramycin, and combination therapies have been used, but none are consistently efficacious.

RESULTS:

We present a case of chronic diarrhea from cryptosporidiosis in a renal transplant patient. His illness resolved with decreasing immunosuppression and treatment with the 3-drug combination of nitazoxanide, azithromycin, and rifaximin.

CONCLUSIONS:

Although current therapies are not reliably effective in the absence of an effective cellular immune response, combination therapies hold promise for improved responses.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos